Literature DB >> 22517070

Stimulation site within the MRI-defined STN predicts postoperative motor outcome.

Fritz Wodarg1, Jan Herzog, René Reese, Daniela Falk, Markus O Pinsker, Frank Steigerwald, Olav Jansen, Günther Deuschl, H Maximillian Mehdorn, Jens Volkmann.   

Abstract

High-frequency stimulation of the subthalamic nucleus (STN-HFS) is highly effective in treating motor symptoms in Parkinson's disease (PD) and medication side effects as well as in improving quality of life. Despite preoperative screening for patients as eligible candidates for this treatment, electrode position may furthermore influence treatment quality. Here, we investigated the relationship between the anatomical site of stimulation within the MRI-defined STN and the outcome of PD patients after STN-HFS. In 30 PD patients with bilateral STN stimulation, we retrospectively defined the boundaries of the STN within the axial target plane of the stereotactic T2-weighted MRI and determined the position of the active electrode contact in relation to the border of the STN. The position of the active contact within the STN was the only variable to predict the outcome of STN stimulation. In contrast, covariates such as age, disease duration, symptom severity, and response to levodopa had no effect. The lateral position of the stimulation contact within the STN led to significantly better clinical improvement, lower stimulation parameters, and less need for postoperative dopaminergic medication. The outcome of patients with stimulation contacts within the medial region of the STN was significantly worse. Precise targeting of the lateral region of the STN is essential for achieving sufficient stimulation efficacy. Preoperative T2-weighted MRI might be a useful component of the targeting procedure to improve the outcome of PD patients.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22517070     DOI: 10.1002/mds.25006

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

1.  Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an Eastern center.

Authors:  Shang-Ming Chiou; Yu-Chin Lin; Ming-Kuei Lu; Chon-Haw Tsai
Journal:  Neurol Sci       Date:  2014-11-14       Impact factor: 3.307

2.  Assessment of a method to determine deep brain stimulation targets using deterministic tractography in a navigation system.

Authors:  Josué M Avecillas-Chasin; Fernando Alonso-Frech; Olga Parras; Nayade Del Prado; Juan A Barcia
Journal:  Neurosurg Rev       Date:  2015-05-12       Impact factor: 3.042

3.  Movement-related discharge in the macaque globus pallidus during high-frequency stimulation of the subthalamic nucleus.

Authors:  Andrew J Zimnik; Gerald J Nora; Michel Desmurget; Robert S Turner
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

Review 4.  Directional Deep Brain Stimulation.

Authors:  Frank Steigerwald; Cordula Matthies; Jens Volkmann
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

5.  Lateralization of the Subthalamic Nucleus with Age in Parkinson's Disease.

Authors:  Julio L B Pereira; Sydney Furie B A; Justin Sharim; Daniel Yazdi; Antonio A F DeSalles; Nader Pouratian
Journal:  Basal Ganglia       Date:  2016-04-01

6.  MRI in patients with implanted active devices: how to combine safety and image quality using a limited transmission field?

Authors:  Laura Lunden; Stephan Wolff; Sönke Peters; Catharina Drews; Christine Gierloff; Ulf Jensen-Kondering; Patrick Langguth; Jawid Madjidyar; Tim-Christian Piesch; Olav Jansen
Journal:  Eur Radiol       Date:  2020-01-23       Impact factor: 5.315

7.  Integrative and Network-Specific Connectivity of the Basal Ganglia and Thalamus Defined in Individuals.

Authors:  Deanna J Greene; Scott Marek; Evan M Gordon; Joshua S Siegel; Caterina Gratton; Timothy O Laumann; Adrian W Gilmore; Jeffrey J Berg; Annie L Nguyen; Donna Dierker; Andrew N Van; Mario Ortega; Dillan J Newbold; Jacqueline M Hampton; Ashley N Nielsen; Kathleen B McDermott; Jarod L Roland; Scott A Norris; Steven M Nelson; Abraham Z Snyder; Bradley L Schlaggar; Steven E Petersen; Nico U F Dosenbach
Journal:  Neuron       Date:  2019-12-10       Impact factor: 17.173

Review 8.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.

Authors:  Yi Wang; Pascal Spincemaille; Zhe Liu; Alexey Dimov; Kofi Deh; Jianqi Li; Yan Zhang; Yihao Yao; Kelly M Gillen; Alan H Wilman; Ajay Gupta; Apostolos John Tsiouris; Ilhami Kovanlikaya; Gloria Chia-Yi Chiang; Jonathan W Weinsaft; Lawrence Tanenbaum; Weiwei Chen; Wenzhen Zhu; Shixin Chang; Min Lou; Brian H Kopell; Michael G Kaplitt; David Devos; Toshinori Hirai; Xuemei Huang; Yukunori Korogi; Alexander Shtilbans; Geon-Ho Jahng; Daniel Pelletier; Susan A Gauthier; David Pitt; Ashley I Bush; Gary M Brittenham; Martin R Prince
Journal:  J Magn Reson Imaging       Date:  2017-03-10       Impact factor: 4.813

9.  Deep brain stimulation in Parkinson's disease: motor effects relative to the MRI-defined STN.

Authors:  Juergen Ralf Schlaier; Christine Hanson; Annette Janzen; Claudia Fellner; Andreas Hochreiter; Martin Proescholdt; Alexander Brawanski; Max Lange
Journal:  Neurosurg Rev       Date:  2014-02-28       Impact factor: 3.042

10.  [Application of intracranial lead reconstruction in deep brain stimulation therapy in patients with Parkinson's disease].

Authors:  Xiaobin Zheng; Lianghong Yu; Xinlong Wan; Huiqing Wang; Ting Yu; Qiu He; Zhangya Lin; Dezhi Kang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.